Distinct characteristics of initiation of the classical and alternative complement pathways by Candida albicans

Infection and Immunity

Volumn 64, Issue 8, 1996, Pages 3360-3368

  Kozel, Thomas R ^a,b   Weinhold, Leanne C ^a   Lupan, David M ^a  

^a UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NEVADA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; IMMUNOGLOBULIN G;

ARTICLE; BINDING KINETICS; CANDIDA ALBICANS; CELL SURFACE; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT FIXATION; COMPLEMENT SYSTEM; HYDROPHILICITY; HYDROPHOBICITY; NONHUMAN; PRIORITY JOURNAL;

EID: 0030056172     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.8.3360-3368.1996     Document Type: Article

References (45)

1. Blum, L. 1964. Evidence for immunological specificity of the properdin System. Demonstration, isolation and properties of a serum factor which interacts with zymosan and other polysaccharides at 0°C. J. Immunol. 92:61-72.
2. Cherniak, R., E. Reiss, and S. H. Turner. 1982. A galactoxylomannan antigen of Cryptococcus neoformans scrotype A. Carbohydr. Res. 103:239-250.
3. Cutler, J. E., and T. Kanbe. 1993. Antigenic variability of Candida albicans cell surface. Curr. Top. Med. Mycol. 5:27-47.
4. Edwards, J. E., Jr., T. A. Gaither, J. J. O'Shea, D. Rotrosen, T. J. Lawley, S. A. Wright, M. M. Frank, and I. Green. 1986. Expression of specific binding sites on Candida with functional and antigenic characteristics of human complement receptors. J. Immunol. 137:3577-3583.
5. Eigentler, A., T. F. Schulz, C. Larcher, E.-M. Breitwieser, B. L. Myones, A. L. Petzer, and M. P. Dierich. 1989. C3bi-binding protein on Candida albicans: temperature-dependent expression and relationship to human complement receptor type 3. Infect. Immun. 57:616-622.
6. Fine, D. P., S. R. Marney, Jr., D. G. Colley, J. S. Sergent, and R. M. Des Prez. 1972. C3 shunt activation in human serum chelated with EGTA. J. Immunol. 109:807-809.
7. Fraker, P. J., and J. C. Speck, Jr. 1978. Protein and cell membrane inodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a, 6a-diphenylglycoluril. Biochem. Biophys. Res. Commun. 80:849-857.
8. Gelfand, J. A., D. L. Hurley, A. S. Fauci, and M. M. Frank. 1978. Role of complement in host defense against experimental disseminated candidiasis. J. Infect. Dis. 138:9-16.
9. Greenfield, R. A., M. J. Bussey, J. L. Stephens, and J. M. Jones. 1983. Serial enzyme-linked immunosorbent assays for antibody to Candida antigens during induction chemotherapy for acute leukemia. J. Infect. Dis. 148:275-283.
10. Greenfield, R. A., J. L. Stephens, M. J. Bussey, and J. M. Jones. 1983. Quantitation of antibody to Candida mannan by enzyme-linked immunosorbent assay. J. Lab. Clin. Med. 101:758-771.
11. Han, Y., and J. E. Cutler. 1995. Antibody response that protects against disseminated candidiasis. Infect. Immun. 63:2714-2719.
12. Harlow, E., and D. Lane. 1996. Antibodies: a laboratory manual, p. 283-318. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
13. Hazen, K. C. 1990. Cell surface hydrophobicity of medically important fungi, especially Candida species, p. 249-295. In R. J. Doyle and M. Rosenberg (ed.), Microbial cell surface hydrophobicity. American Society for Microbiology, Washington, D.C.
14. Hazen, K. C., D. L. Brawner, M. H. Riesselman, M. A. Jutila, and J. E. Cutler. 1991. Differential adherence of hydrophobic and hydrophilic Candida albicans yeast cells to mouse tissues. Infect. Immun. 59:907-912.
15. Hazen, K. C., and P. M. Glee. 1994. Hydrophobic cell wall protein glycosylation by the pathogenic fungus Candida albicans. Can. J. Microbiol. 40:266-272.
16. Hazen, K. C., and B. W. Hazen. 1987. A polystyrene microsphere assay for detecting cell surface hydrophobicity heterogeneity within Candida albicans populations. J. Microbiol. Methods 6:289-299.
17. Hazen, K. C., and B. W. Hazen. 1992. Hydrophobic surface protein masking by the opportunistic fungal pathogen Candida albicans. Infect. Immun. 60: 1499-1508.
18. Hazen, K. C., and B. W. Hazen. 1993. Surface hydrophobic and hydrophilic protein alterations in Candida albicans. FEMS Microbiol. Lett. 107:83-88.
19. Hector, R. F., J. E. Domer, and E. W. Carrow. 1982. Immune responses to Candida albicans in genetically distinct mice. Infect. Immun. 38:1020-1028.
20. Heidenreich, F., and M. P. Dierich. 1985. Candida albicans and Candida stellatoidea, in contrast to other Candida species, bind iC3b and C3d but not C3b. Infect. Immun. 50:598-600.
21. Ikeda, K., T. Sannoh, N. Kawasaki, T. Kawasaki, and I. Yamashina. 1987. Serum lectin with known structure activates complement through the classical pathway. J. Biol. Chem. 262:7451-7454.
22. James, P. G., R. Cherniak, R. G. Jones, C. A. Stortz, and E. Reiss. 1990. Cell-wall glucans of Cryptococcus neoformans CAP 67. Carbohydr. Res. 198:23-38.
23. Jones, J. M. 1980. Quantitation of antibody against cell wall mannan and a major cytoplasmic antigen of Candida in rabbits, mice, and humans. Infect. Immun. 30:78-89.
24. Keller, R. G., G. S. T. Pfrommer, and T. R. Kozel. 1994. Occurrences, specificities, and functions of ubiquitous antibodies in human serum that are reactive with the Cryptococcus neoformans cell wall. Infect. Immun. 62:215-220.
25. Kocourek, J., and C. E. Ballou. 1969. Method for fingerprinting yeast cell wall mannans. J. Bacteriol. 100:1175-1181.
26. Kozel, T. R., R. R. Brown, and G. S. T. Pfrommer. 1987. Activation and binding of C3 by Candida albicans. Infect. Immun. 55:1890-1894.
27. Kozel, T. R., G. S. T. Pfrommer, A. S. Guerlain, B. A. Highison, and G. J. Highison. 1988. Strain variation in phagocytosis of Cryptococcus neoformans: dissociation of susceptibility to phagocytosis from activation and binding of opsonic fragments of C3. Infect. Immun. 56:2794-2800.
28. Kozel, T. R., M. A. Wilson, G. S. T. Pfrommer, and A. M. Schlageter. 1989. Activation and binding of opsonic fragments of C3 on encapsulated Cryptococcus neoformans by using an alternative complement pathway reconstituted from six isolated proteins. Infect. Immun. 57:1922-1927.
29. Kozel, T. R., M. A. Wilson, and W. H. Welch. 1992. Kinetic analysis of the amplification phase for activation and binding of C3 to encapsulated and nonencapsulated Cryptococcus neoformam. Infect. Immun. 60:3122-3127.
30. Lehmann, P. F., and E. Reiss. 1980. Comparison by ELISA of serum anti-Candida albicans mannan IgG levels of a normal population and in diseased patients. Mycopathologia 70:89-93.
31. Liebert, R. E., and K. C. Hazen. 1988. Relationship of cell surface hydrophobicity to morphology of monomorphic and dimorphic fungi. Mycologia 80:348-355.
32. 2 complex, of the classical pathway of complement, without involvement of Clq. J. Immunol. 144:2287-2294.
33. Morelli, R., and L. T. Rosenberg. 1971. The role of complement in the phagocytosis of Candida albicans by mouse peripheral blood leukocytes. J. Immunol. 107:476-480.
34. Morelli, R., and L. T. Rosenberg. 1971. Role of complement during experimental Candida infection in mice. Infect. Immun. 3:521-523.
35. Morrison, R. P., and J. E. Cutler. 1981. In vitro studies of the interaction of murine phagocytic cells with Candida albicans. J. Reticuloendothel. Soc. 29:23-34.
36. Ohta, M., M. Okada, I. Yamashina, and T. Kawasaki. 1990. The mechanism of carbohydrate-mediated complement activation by the serum mannan-binding protein. J. Biol. Chem. 265:1980-1984.
37. Platts-Mills, T. A. E., and K. Ishizaka. 1974. Activation of the alternative pathway of human complement by rabbit cells. J. Immunol. 113:348-357.
38. Poulain, D., G. Tronchin, J. F. Dubremetz, and J. Biguet. 1978. Ultrastructure of the cell wall of Candida albicans blastospores: study of its constitutive layers by the use of a cytochemical technique revealing polysaccharidcs. Ann. Microbiol. (Inst. Pasteur) 129:141-153.
39. Ray, T. L., and K. D. Wuepper. 1976. Activation of the alternative (properdin) pathway of complement by Candida albicans and related species. J. Invest. Dermatol. 67:700-703.
40. Summers, D. F., A. P. Grollman, and H. F. Hasenclever. 1964. Polysaccha ride antigens of Candida cell wall. J. Immunol. 92:491-499.
41. Tack, B. F., J. Janatova, M. L. Thomas, R. A. Harrison, and C. H. Hammer. 1981. The third, fourth, and fifth components of human complement: isolation and biochemical properties. Methods Enzymol. 80:64-101.
42. Thong, Y. H., and A. Ferrante. 1978. Alternative pathway of complement activation by Candida albicans. Aust. N. Z. J. Med. 8:620-622.
43. Tronchin, G., J. P. Bouchara, and R. Robert. 1989. Dynamic changes of the cell wall surface of Candida albicans associated with germination and adherence. Eur. J. Cell Biol. 50:285-290.
44. Wilson, M. A., and T. R. Kozel. 1992. Contribution of antibody in normal human serum to early deposition of C3 onto encapsulated and nonencapsulated Cryptococcus neoformans. Infect. Immun. 60:754-761.
45. Young, B. J., and T. R. Kozel. 1993. Effects of strain variation, serotype and structural modification on the kinetics for activation and binding of C3 to Cryptococcus neoformans. Infect. Immun. 61:2966-2972.